These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21305147)

  • 1. Novel gold(I) phosphine compounds inhibit HIV-1 enzymes.
    Fonteh P; Meyer D
    Metallomics; 2009 Sep; 1(5):427-33. PubMed ID: 21305147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) chloride: An HIV-1 reverse transcriptase and protease inhibitor.
    Fonteh PN; Keter FK; Meyer D; Guzei IA; Darkwa J
    J Inorg Biochem; 2009 Feb; 103(2):190-4. PubMed ID: 19019450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?
    Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Gago F
    Antiviral Res; 2006 Sep; 71(2-3):260-7. PubMed ID: 16872687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
    Pereira CF; Paridaen JT; van de Bovenkamp M; Middel J; Verhoef J; Nottet HS
    J Antimicrob Chemother; 2003 May; 51(5):1181-9. PubMed ID: 12668583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus.
    Kapewangolo P; Hussein AA; Meyer D
    J Ethnopharmacol; 2013 Aug; 149(1):184-90. PubMed ID: 23811046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV therapeutic possibilities of gold compounds.
    Fonteh PN; Keter FK; Meyer D
    Biometals; 2010 Apr; 23(2):185-96. PubMed ID: 20127392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.
    Lee JS; Hattori M; Kim J
    Planta Med; 2008 Apr; 74(5):532-4. PubMed ID: 18543149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
    Gupta P; Kumar R; Garg P; Singh IP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.
    Herschhorn A; Hizi A
    J Med Chem; 2008 Sep; 51(18):5702-13. PubMed ID: 18800765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors.
    Leitão A; Andricopulo AD; Montanari CA
    Eur J Med Chem; 2008 Jul; 43(7):1412-22. PubMed ID: 17954002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays.
    Mphahlele M; Papathanasopoulos M; Cinellu MA; Coyanis M; Mosebi S; Traut T; Modise R; Coates J; Hewer R
    Bioorg Med Chem; 2012 Jan; 20(1):401-7. PubMed ID: 22104436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.
    ter Heine R; Davids M; Rosing H; van Gorp EC; Mulder JW; van der Heide YT; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):575-80. PubMed ID: 19168402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors.
    Olomola TO; Klein R; Mautsa N; Sayed Y; Kaye PT
    Bioorg Med Chem; 2013 Apr; 21(7):1964-71. PubMed ID: 23415084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
    Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
    Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
    Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
    J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
    Sarafianos SG; Hughes SH; Arnold E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.